Publications by authors named "Nilofer Azad"

Claim this Profile
B
Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials.
Fen Saj, Felicity K Namayanja, Lianchun Xiao, Mitesh J Borad, Robin Kate Kelley, Nilofer S Azad

Cancer· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final Results from a First-in-Human Phase I Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations.
James J Harding, Do-Youn Oh, Teresa Macarulla Mercade, Lipika Goyal, Andreas Varkaris, Nilofer Azad

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair-Proficient Colorectal Cancer.
Eric S Christenson, Won Jin Ho, Daniel Shu, Jennifer N Durham, Madelena Brancati, Nilofer Azad

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained Organ Preservation in Patients With Rectal Cancer After Sequential Short-Course Radiation Therapy and Chemotherapy.
I-Chia Liu, Susan Gearhart, Chen Hu, Haniee Chung, Alodia Gabre-Kidan, Nilofer S Azad

Am Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of intratumourally administered INT230-6 in adult patients with advanced solid tumours: results from an open-label phase 1/2 dose escalation study.
Jacob S Thomas, Lillian L Siu, Matthew Ingham, Nilofer S Azad, Christian F Meyer

EBioMedicine· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling ADC targets in cholangiocarcinoma: implications for therapeutic development.
Mari Nakazawa, Waqar Arif, Ezra Baraban, Andres Matoso, Elsa Hallab, Nilofer S Azad

NPJ Precis Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-derived CCL2 drives tumor growth and immunosuppression in IDH1- mutant cholangiocarcinoma.
Daniel J Zabransky, Emma Kartalia, Jae W Lee, James M Leatherman, Soren Charmsaz, Nilofer S Azad

Hepatology· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair-Proficient Colorectal Cancer.
Eric S Christenson, Won Jin Ho, Daniel Shu, Jennifer N Durham, Madelena Brancati, Nilofer Azad

Clin Cancer Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial proteomics and transcriptomics reveal early immune cell organization in pancreatic intraepithelial neoplasia.
Melissa R Lyman, Jacob T Mitchell, Sidharth Raghavan, Luciane T Kagohara, Amanda L Huff, Nilofer S Azad

JCI Insight· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor site influences efficacy of MEKi and immunotherapy combinations in a preclinical model of cholangiocarcinoma.
Jacklyn N Hammons, Emilie K Warren, Megen C Wittling, Frances J Bennett, Guillermo O Rangel-Rivera, Nilofer N S Azad

Hepatology· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1.
Jordina Rincon-Torroella, Marco Dal Molin, Brian Mog, Gyuri Han, Evangeline Watson, Nilofer Azad

Elife· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-Based Strategies for Pancreatic Cancer in the Adjuvant Setting.
Kai-Li Liang, Nilofer S Azad

Cancers (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep immune profiling of intrahepatic cholangiocarcinoma with CODEX multiplexed imaging.
Marina Baretti, Soumya Shekhar, Vaibhav Sahai, Daniel Shu, Kathryn Howe, Nilofer S Azad

Hepatol Commun· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-Generation Sequencing-Based MSI Scoring Predicts Benefit in Mismatch Repair-Deficient Tumors Treated with Nivolumab: Follow-up on NCI-MATCH Arm Z1D.
Jonathan D Schoenfeld, Nilofer S Azad, Jacob Gross, Li Chen, Michael J Overman

Clin Cancer Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib in treatment-refractory isocitrate dehydrogenase 1 (IDH1)- and IDH2-mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer Institute 10129 trial.
Michael Cecchini, Mary Jo Pilat, Nataliya Uboha, Nilofer S Azad, May Cho

Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center Oncology Clinic.
Hassan Sinan, Dea Cunningham, Emy Abou Sleiman, Dana Petry, Thomas McPhaul, Nilofer S Azad

JCO Precis Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of recurrence after curative intent hepatic resection for colorectal liver metastasis.
Heng-Chung Kung, Christopher Shubert, Catherine Wilbur, Will Burns, Richard Burkhart, Nilofer S Azad

J Gastrointest Surg· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SpliceMutr Enables Pan-Cancer Analysis of Splicing-Derived Neoantigen Burden in Tumors.
Theron Palmer, Michael D Kessler, Xiaoshan M Shao, Archana Balan, Mark Yarchoan, Nilofer S Azad

Cancer Res Commun· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trial.
Marina Baretti, Ludmila Danilova, Jennifer N Durham, Courtney B Betts, Leslie Cope, Nilofer S Azad

Nat Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.
Petros Grivas, Elena Garralda, Funda Meric-Bernstam, Ingo K Mellinghoff, Lipika Goyal, Nilofer S Azad

Clin Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTC.
Nilofer Azad, Zishuo Hu, Ilyas Sahin, Renuka Iyer, Olivia Aranha

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of adenosquamous pancreatic cancer with a KRAS G12C mutation with an exceptional response to immunotherapy.
Murtaza Ahmed, Brent K Larson, Arsen Osipov, Nilofer Azad, Andrew Hendifar

Oncotarget· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unlocking the promise of RAS inhibition in pancreatic cancer.
Saurav D Haldar, Nilofer S Azad

Nat Rev Gastroenterol Hepatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for the treatment of biliary tract cancer: an evolving landscape.
Helen Catherine Wilbur, Nilofer S Azad

Ther Adv Med Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoreductive single-fraction stereotactic radiation therapy prior to living donor transplantation for inoperable liver-confined metastatic rectal cancer.
Panos A Papanikolaou, Russell N Wesson, Nilofer S Azad, Jeffrey J Meyer

J Radiosurg SBRT· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis